公司愿景——专注于原创药全球同步开发

为重大疾病治疗提供突破性创新产品
新药研发创业者的助推器
共同成长为全球具有影响力的制药企

 

地址:北京市经济开发区科创六街88号(生物医药园)F2楼

电话:010-56315466       传真:010-56315314

邮箱:hr@jacobiopharma.com

北京加科思科新药研发有限公司     京CIP07097878    中企动力提供技术支持

Jacobio Receives IND Approval for CD73 mAb JAB-BX102 from China CDE

Jacobio Receives IND Approval for CD73 mAb JAB-BX102 from China CDE

Release time:
2022-03-28 11:03
Abstract:
Jacobio plans to initiate global clinical trials of JAB-BX102
Jacobio Announces Annual Results of 2021, R&D Investment Increases 83%

Jacobio Announces Annual Results of 2021, R&D Investment Increases 83%

Release time:
2022-03-23 04:09
Abstract:
Reveune was RMB152 million, R&D investment was RMB421 million.
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China

Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China

Release time:
2022-02-24 18:32
Abstract: